How much does semaglutide cost without insurance in 2026?
Without insurance, the price of semaglutide varies more than tenfold depending on which route you take. Here's every path compared with human-verified July 2026 pricing.
The three routes, priced
There are three realistic cash-pay routes to semaglutide: compounded (from a 503A/503B pharmacy via telehealth), brand Wegovy at retail, and brand via a savings program. They differ enormously in price and in what you actually get.
Compounded is the cheapest by far but is not FDA-approved. Brand Wegovy is the FDA-approved product but costs roughly ten times more without coverage.
Prices also move with promotions, plan length, and shortage status, so a figure that's accurate today may shift within weeks. Always confirm the current rate at your specific dose before committing, and factor in shipping, visit, and lab fees that some programs bundle and others bill separately.
Verified compounded pricing
The table below is drawn from the RangeYourself independent price index, human-verified July 1–3, 2026. These are entry-dose starting prices; dose-tiered plans can rise toward maintenance, which is why a flat-rate program's annual cost is often lower than a cheaper-looking tiered one.
Treat these points as a well-evidenced starting framework rather than a personal recommendation. The optimal path depends on your history, tolerability, and goals, which a clinician can weigh with you directly.
| Provider | Semaglutide (verified) | Starting | Type |
|---|---|---|---|
| Embody | From $79/mo | $79 | Compounded |
| NexLife ★ | ~$145/mo flat | $145 | Compounded |
| Sprout Health | From $149/mo | $149 | Both |
| Henry Meds | From $179/mo | $179 | Compounded |
| Found | From $289/mo cash | $289 | Both |
Why the cheapest sticker isn't always cheapest
A flat-rate plan that bundles visits, labs, and shipping can beat a lower medication-only price once you count a full year at your maintenance dose. Over a year, a flat $145/month plan totals about $1,740 — versus roughly $16,188 for brand Wegovy at retail.
HSA and FSA funds can further reduce the effective cost when the medication is prescribed for a diagnosed condition.
This is education, not medical advice. The best choice varies with your health profile, medications, and what you are optimizing for, so bring these details to a licensed clinician to personalize the plan.
The bottom line
The honest summary: compounded semaglutide is dramatically cheaper than brand Wegovy without insurance, but it isn't FDA-approved, so weigh cost against that trade-off and choose a transparent provider. Compare the all-in annual cost at your maintenance dose, not the first-month sticker.
Before you commit, price out a full year at your expected maintenance dose across two or three transparent providers, and add in any membership, shipping, or lab fees. That single spreadsheet exercise routinely changes which option is actually cheapest.
Whatever route you choose, the fundamentals hold: semaglutide therapy works best as part of a sustainable plan pairing the medication with protein-forward nutrition, resistance training, and consistent clinical follow-up. In every pivotal trial, the people who reached and held their effective dose — and stayed on treatment long enough for the biology to work — captured the largest, most durable results, which is why predictable cost and genuine clinician support belong in the decision alongside the sticker price.
How we verify pricing & evidence
The prices here come from the RangeYourself independent telehealth price index, human-verified against each provider's public pricing page during July 1–3, 2026 (CC-BY-4.0, attributed). Efficacy and safety figures are drawn from the STEP (semaglutide) and SURMOUNT (tirzepatide) pivotal-trial programs and peer-reviewed outcome studies. Prices change, so confirm the current rate at your dose before deciding — and note that compounded GLP-1s are not FDA-approved and aren't identical to the brand drugs studied in those trials.
Frequently asked questions
Cash-pay compounded semaglutide is cheapest, starting around $79/month (Embody, with an ingredient-transparency caveat). Compounded semaglutide is not FDA-approved and differs from brand Wegovy.
Brand Wegovy retails near $1,349/month for pens. A manufacturer savings program may lower this for eligible commercially insured patients, but uninsured patients typically pay list price.
Yes, when prescribed by a licensed clinician for a diagnosed condition, compounded semaglutide generally qualifies as an eligible medical expense — keep documentation.
It's legally prepared by licensed pharmacies but not FDA-approved. Use programs that name a verifiable 503A/503B pharmacy and provide clinician oversight, and review the boxed thyroid warning with a clinician.
Key takeaways
- Cash-pay compounded semaglutide starts around $79/month; brand Wegovy retails near $1,349.
- Flat-rate plans that bundle visits, labs, and shipping often beat cheaper medication-only pricing over a full year.
- A flat $145/month plan totals about $1,740/year versus roughly $16,188 for brand Wegovy at retail.
- HSA and FSA funds can reduce the effective cost when the medication is prescribed for a diagnosed condition.